Deltex Medical Group (DEMG) has received an Innovative Technology contract from Vizient Inc. the largest member-driven health care performance improvement company in the United States.
Vizient awards such contracts to technologies that “identify breakthrough solutions that can improve patient care or reduce the risk of harm to patients or providers, while simultaneously raising the standard of patient care and safety.”
Based on the recommendation of hospital experts in haemodynamics, Deltex’s focus, Vizient has ordered the CardioQ-EDM+, a device that measures blood flow velocity in the central circulation in real time.
The validation of receiving this contract builds on Deltex’s reputation as “the only company in the enhanced haemodynamic space to have built a robust evidence base demonstrating both the clinical and economic benefits of its core technology.”
CEO of Deltex Medical, Andy Mears commented, “The Board is appreciative of the award of this prestigious Vizient Innovative Technology contract, which recognises the important role the CardioQ-EDM+ plays in improving patient safety during and after surgery.”
For more news and updates from Deltex Medical Group: